GlassScriptPhysician profile
Luke Meade Williams
NPI 1659347854
$16,442.27
in general payments reported to CMS, 2019-2025
30 companies · $2,499 in 2025
The $2,499 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,297 · 2020: $1,635 · 2021: $2,088 · 2022: $2,585 · 2023: $2,760 · 2024: $2,579 · 2025: $2,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,764 · Education: $73.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,763.56 |
| Education | $73.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,555.19 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $3,369.12 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Genzyme Corporation | $1,343.56 | 2019-2025 | |
| Mylan Specialty L.P. | $1,131.60 | 2019-2024 | Yupelri |
| Csl Behring | $1,072.68 | 2019-2025 | Hizentra |
| Regeneron Healthcare Solutions, INC. | $871.23 | 2019-2025 | Dupixent |
| Sunovion Pharmaceuticals INC. | $844.25 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.58 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Insmed, INC. | $339.40 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $318.02 | 2019-2024 | (Ak6) Vest Therapy |
| Viatris Specialty LLC | $264.08 | 2025 | Yupelri |
| Amgen INC. | $237.19 | 2024-2025 | Tezspire |
| United Therapeutics Corporation | $186.09 | 2019-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $183.54 | 2021-2023 | |
| Baxter Healthcare | $166.68 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $160.71 | 2020-2023 | Prolastin-C Liquid |
| Advanced Respiratory, INC | $126.59 | 2019-2021 | |
| Intuitive Surgical, INC. | $125.56 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $108.57 | 2019-2023 | Opsumit |
| Verona Pharma, INC. | $105.88 | 2025 | Ohtuvayre |
| Hologic Sales and Service, LLC | $77.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Ambu INC. | $42.00 | 2020 | |
| Merck Sharp & Dohme LLC | $34.86 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.69 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.36 | 2021 | |
| Gilead Sciences, INC. | $25.75 | 2019 | |
| Biomerieux INC | $22.29 | 2021 | |
| Tactile Systems Technology INC | $21.26 | 2023 | Flexitouch Plus, Entre Plus |
| Boston Scientific Corporation | $19.12 | 2023 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.